中文 | English
Return
Total: 554 , 1/56
Show Home Prev Next End page: GO
Author:(hong Rui WEI)

1.Progress of stem cell technology in the study of endocrine and metabolic diseases

Rui WEI ; Tianpei HONG

Chinese Journal of Endocrinology and Metabolism 2014;30(3):250-253

2.Protective cardiovascular effects of metformin in type 2 diabetic patients: evidence and underlying mechanisms

Huijie AN ; Rui WEI ; Tianpei HONG

Chinese Journal of Endocrinology and Metabolism 2013;29(9):735-739

3.Cardiovascular protective effects of glucagon-like peptide-1 agents in patients with type 2 diabetes

Jing KE ; Rui WEI ; Tianpei HONG

Chinese Journal of Endocrinology and Metabolism 2015;(9):812-815

4.Implication of proinsulin to insulin ratio in the basic and clinical research of diabetes

Junling LIU ; Rui WEI ; Tianpei HONG

Chinese Journal of Endocrinology and Metabolism 2017;33(5):449-452

5.Protective effects and potential mechanism of the SGLT2 inhibitor on islet β cells

Kangli WANG ; Tianpei HONG ; Rui WEI

Chinese Journal of Endocrinology and Metabolism 2021;37(4):297-300

8.Effect of Dimethyl Dicarboxylate Biphenyl (DDB) on the Proliferation, Apoptosis and PPARγExpression of Hepatic Stellate Cells

Danyun WEI ; Hong ZHANG ; Ying ZHANG ; Rui PEN

China Pharmacist 2016;19(3):413-416

9.Glucagon-like peptide-1 : New target for treating non-alcoholic fatty liver disease?

Ye LIU ; Tianpei HONG ; Rui WEI ; Jin YANG

Chinese Journal of Endocrinology and Metabolism 2015;31(5):386-389

10.Relationship between the rehabilitative intervention of ischemic cerebrovascular diseases and the functional alteration of monomer polymerization of fibrinogen

Mei HONG ; Wenning WEI ; Hongge LI ; Rui YANG ; Yan YANG

Chinese Journal of Tissue Engineering Research 2005;9(5):238-240

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 554 , 1/56 Show Home Prev Next End page: GO